The blurb runs thus………A major theme this year in the medicinal psychedelics sphere has been investment. Those who’ve been paying attention know that hardly a week passed without talk of an upcoming IPO, an important funding round, or some high-profile investor activity. One of the positive things to come out of this long strange year is the fact that the investment community is alive to the opportunities psychedelics present. This is important to the long-term success (not just short term gains) of psychedelic medicine, and enabling it to reach those in need. What have we learned this year? What can we look forward to in 2021? PsyTech has assembled a round table of deeply embedded cannabis and psychedelics investment, business, and data leaders to shed light on the state of psychedelics as the new year approaches. Join us as we discuss today’s most important investment topics, including practical investment advice in this rapidly emerging space.

Here’s all the presenters